Loading…
To suspend temporarily the rate of duty on Oleo Turmeric.
Legislative Progress
Introduced
April 26, 2012
Latest Action
May 2, 2012
Primary Sponsor
C. A. Dutch RuppersbergerDemocratic(MD)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
37pct
6d open
vs 6,662 other HR bills in the 112th — cohort avg 39d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (1)
2012 · second_quarter · Copyright/Patent/Trademark
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation Risk Evaluation and Mitigation Strategies for controlled substances HR 4956 - Stop Oxy Abuse Act HR 6169 - STOPP Act
Client expense: $60,000 · Firm income: Not reported
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2012 · second_quarter · Alcohol and Drug Abuse
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation Risk Evaluation and Mitigation Strategies for controlled substances HR 4956 - Stop Oxy Abuse Act HR 6169 - STOPP Act
Client expense: $60,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2012 · second_quarter · Health Issues
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation Risk Evaluation and Mitigation Strategies for controlled substances HR 4956 - Stop Oxy Abuse Act HR 6169 - STOPP Act
Client expense: $60,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2012 · first_quarter · Health Issues
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 - Stop Oxy Abuse Act
Client expense: $300,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2012 · first_quarter · Alcohol and Drug Abuse
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 - Stop Oxy Abuse Act
Client expense: $300,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2012 · first_quarter · Copyright/Patent/Trademark
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 - Stop Oxy Abuse Act
Client expense: $300,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2012 · first_quarter · Health Issues
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 - Stop Oxy Abuse Act
Client expense: $3,000,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2012 · first_quarter · Copyright/Patent/Trademark
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 - Stop Oxy Abuse Act
Client expense: $3,000,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2012 · first_quarter · Alcohol and Drug Abuse
Anti- counterfeiting legislation concerning drugs (pedigree) Disposal of Drugs Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation RiskEvaluation and MitigationStrategies for controlled substances HR 4956 - Stop Oxy Abuse Act
Client expense: $3,000,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE